tiprankstipranks
Trending News
More News >
Arch Biopartners (TSE:ARCH)
:ARCH
Canadian Market

Arch Biopartners (ARCH) Financial Statements

Compare
42 Followers

Arch Biopartners Financial Overview

Arch Biopartners's market cap is currently C$66.26M. The company's EPS TTM is C$; its P/E ratio is -41.77; Arch Biopartners is scheduled to report earnings on January 29, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 2.12MC$ 1.98MC$ 964.68KC$ 3.89M
Gross ProfitC$ 0.00C$ -1.66MC$ -129.00KC$ -503.00KC$ -150.00K
Operating IncomeC$ -1.52MC$ -3.95MC$ -3.35MC$ -1.39MC$ -1.17M
EBITDAC$ -1.29MC$ -3.53MC$ -336.00KC$ -101.00KC$ -77.02K
Net IncomeC$ -1.55MC$ -3.92MC$ -3.33MC$ -1.41MC$ -1.17M
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.10KC$ 2.97KC$ 831.27KC$ 506.35KC$ 448.24K
Total AssetsC$ 104.53KC$ 935.62KC$ 1.17MC$ 621.64KC$ 2.67M
Total DebtC$ 2.84MC$ 2.77MC$ 5.02MC$ 4.41MC$ 5.16M
Net DebtC$ 2.84MC$ 2.77MC$ 4.18MC$ 3.91MC$ 4.72M
Total LiabilitiesC$ 3.99MC$ 5.28MC$ 6.68MC$ 5.09MC$ 6.55M
Stockholders' EquityC$ -3.88MC$ -4.35MC$ -5.51MC$ -4.47MC$ -3.88M
Cash Flow
Free Cash FlowC$ -1.58MC$ -2.33MC$ -234.08KC$ -1.08MC$ -2.98M
Operating Cash FlowC$ -1.58MC$ -2.33MC$ -234.07KC$ -1.08MC$ -2.98M
Investing Cash FlowC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 1.58MC$ 1.50MC$ 559.00KC$ -421.37KC$ 2.78M
Currency in CAD

Arch Biopartners Earnings and Revenue History

Arch Biopartners Debt to Assets

Arch Biopartners Cash Flow

Arch Biopartners Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.